@caterina.beauty's Ozempic injection guide, fact-checked
Quick answer
The video demonstrates subcutaneous injection technique for a semaglutide pen device, covering needle attachment, priming, dose dialing, and post-injection dwell time. The creator's instruction that priming occurs only once per pen is inconsistent with Novo Nordisk's prescribing information, which requires a flow check before each injection after attaching a new needle. No dose or indication guidance is given, which is appropriate for a lay tutorial, though the absence of injection site rotation advice is a clinically relevant omission.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @caterina.beauty actually say?
The creator walked through the steps of priming and injecting with an Ozempic pen. She described removing two needle caps, priming the pen by turning the dose selector to "the first line" and pressing the plunger until medication appears, dialing the dose, inserting the needle fully, and holding the plunger for six seconds before removing. That is the basic shape of correct technique. But some of the language is muddled enough to cause real confusion.
She refers to the dose window as "door styles" throughout, which is clearly a speech or transcription artifact for "dose dial" or "dose window." She also says the needle "is only planned the first time you use the pin," which appears to mean priming is a once-off step. That is wrong, and it matters.
Does the science back this up?
The core injection sequence she describes is broadly consistent with Novo Nordisk's own prescribing information and patient guides for semaglutide (Ozempic). The six-second hold after pressing the plunger is real guidance, not invented. A 2022 review by Flood et al. in Diabetes Therapy found that inadequate needle dwell time is one of the most common causes of incomplete dose delivery with auto-injector and dial-a-dose pens.
The instruction to push the needle "all the way into the skin" is consistent with standard subcutaneous injection technique for most adults. Research published by Hirsch et al. (2014, Diabetes Technology and Therapeutics) confirmed that for most patients using 4mm or 5mm pen needles, a 90-degree insertion without skin lifting is appropriate and avoids intramuscular injection. Nothing in her technique advice contradicts this.
What did they get wrong (or right)?
The biggest error is the claim that priming is done only once, on the first use of the pen. Novo Nordisk's official Ozempic instructions are explicit: you prime the pen before every new needle is attached, not just at the start of a new pen. Every time you swap needles, air and small amounts of medication can enter the needle hub, and priming clears that. Skipping it risks delivering less medication than intended.
She gets the discard step right: the inner needle cap is thrown away, the outer cap is kept to remove the needle afterward. That is correct and actually important, since recapping with the outer cap before disposal reduces needlestick risk.
The six-second count before withdrawal deserves credit. It is not dramatic filler. Insulin and GLP-1 pen studies consistently show that patients who withdraw immediately after pressing the plunger lose a measurable amount of dose from the injection site. The six-second window allows pressure to dissipate and medication to disperse.
One genuine gap: she does not mention injection site rotation. Semaglutide should be rotated across the abdomen, thigh, and upper arm to prevent lipohypertrophy, a condition where repeated injections in the same spot cause fatty tissue buildup that impairs absorption (Blanco et al., 2013, Diabetes Care).
What should you actually know?
If you are using an Ozempic pen, prime it before every injection, not just the first time you open a new pen. Attach a fresh needle, point it up, dial to the flow check symbol, press until you see a drop or small stream of medication, then dial your prescribed dose. Do not use the dose your TikTok creator used. Your dose is between you and your prescribing clinician.
Australia's Therapeutic Goods Administration classifies semaglutide as a Schedule 4 prescription-only medication. Using it without a valid prescription is not legal, and sourcing it from unregulated suppliers carries serious risks including counterfeit product and incorrect concentration. Ozempic (0.5mg, 1mg, 2mg per dose) and Wegovy (2.4mg) are different products with different approved indications. They are not interchangeable without clinical oversight.
- Prime before every injection, not just the first
- Rotate injection sites each week to reduce tissue damage
- Hold the plunger for at least six seconds before withdrawing
- Store unused pens in the fridge; in-use pens can be kept at room temperature for up to 56 days
- Always use a new needle for each injection to reduce infection risk and ensure accurate dosing
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @caterina.beauty's Ozempic injection guide, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Claim verdict
The useful answer behind this video
Claim being checked
The video demonstrates subcutaneous injection technique for a semaglutide pen device, covering needle attachment, priming, dose dialing, and post-injection dwell time.
FormBlends verdict
The video demonstrates subcutaneous injection technique for a semaglutide pen device, covering needle attachment, priming, dose dialing, and post-injection dwell time. The creator's instruction that priming occurs only once per pen is inconsistent with Novo Nordisk's prescribing information, which requires a flow check before each injection after attaching a new needle. No dose or indication guidance is given, which is appropriate for a lay tutorial, though the absence of injection site rotation advice is a clinically relevant omission.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video demonstrates subcutaneous injection technique for a semaglutide pen device, covering needle attachment, priming, dose dialing, and post-injection dwell time. The creator's instruction that priming occurs only once per pen is inconsistent with Novo Nordisk's prescribing information, which requires a flow check before each injection after attaching a new needle. No dose or indication guidance is given, which is appropriate for a lay tutorial, though the absence of injection site rotation advice is a clinically relevant omission.
- Prime the Ozempic pen before every injection after attaching a new needle, not only when opening a new pen for the first time.
- A six-second post-injection hold is evidence-backed: Flood et al. (2022, Diabetes Therapy) linked premature withdrawal to measurable dose loss.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- Prime the Ozempic pen before every injection after attaching a new needle, not only when opening a new pen for the first time.
- A six-second post-injection hold is evidence-backed: Flood et al. (2022, Diabetes Therapy) linked premature withdrawal to measurable dose loss.
- Injection site rotation across the abdomen, thigh, and upper arm is necessary to prevent lipohypertrophy, which impairs semaglutide absorption (Blanco et al., 2013, Diabetes Care).
- In Australia, semaglutide is a Schedule 4 prescription-only drug under the TGA; obtaining it without a valid script is unlawful.
- Ozempic and Wegovy contain the same active ingredient but are approved at different doses for different indications and cannot be used interchangeably without prescriber oversight.
- Always attach a new needle for each injection: reusing needles increases infection risk and can cause needle tip deformation that affects dose accuracy.
- Unopened Ozempic pens should be refrigerated at 2-8 degrees Celsius; in-use pens can be stored below 30 degrees for up to 56 days.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Caterina Beauty · TikTok creator
56.4K views on this video
#howtouseozempic #ozempicaustralia #fyp #australia How the use ozempic pen.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Caterina Beauty, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.